Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$61,335,885
+$6,641,507 QoQ
Shares Held
169,380
+9.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#196
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $928,724,025 across 9 Drug Manufacturers - General names. AMGN ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
257,172 | $308,459,837 | |
| 2 | JNJ |
Johnson & Johnson
|
753,095 | $191,263,537 | |
| 3 | ABBV |
AbbVie Inc.
|
548,411 | $138,002,144 | |
| 4 | MRK |
Merck & Co., Inc.
|
786,562 | $101,073,217 | |
| 5 | AMGN |
Amgen Inc
This page
|
169,380 | $61,335,885 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
321,765 | $40,651,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
690,291 | $39,774,567 | |
| 8 | PFE |
Pfizer Inc
|
1,568,204 | $37,762,352 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,335,885 | 169,380 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $54,694,378 | 155,448 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $23,191,877 | 70,856 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $5,253,894 | 18,817 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $39,787,115 | 127,707 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $26,192,495 | 100,493 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $24,662,597 | 76,542 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $34,226,397 | 109,542 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $34,843,984 | 122,552 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $33,569,307 | 116,552 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $28,182,711 | 104,862 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $23,100,514 | 104,047 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,480,212 | 88,853 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $22,339,107 | 85,056 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $29,883,306 | 132,579 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $15,604,045 | 64,135 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $15,509,125 | 64,135 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $14,428,450 | 64,135 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $14,034,900 | 66,000 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $16,087,500 | 66,000 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $16,421,460 | 66,000 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $15,174,720 | 66,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $16,774,560 | 66,000 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $15,566,760 | 66,000 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $18,150,214 | 89,529 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||